HRP20100733T1 - Glukoza izomeraze za uporabu u liječenju intolerancije fruktoze - Google Patents

Glukoza izomeraze za uporabu u liječenju intolerancije fruktoze Download PDF

Info

Publication number
HRP20100733T1
HRP20100733T1 HR20100733T HRP20100733T HRP20100733T1 HR P20100733 T1 HRP20100733 T1 HR P20100733T1 HR 20100733 T HR20100733 T HR 20100733T HR P20100733 T HRP20100733 T HR P20100733T HR P20100733 T1 HRP20100733 T1 HR P20100733T1
Authority
HR
Croatia
Prior art keywords
glucose isomerase
use according
fructose
tablets
isomerase
Prior art date
Application number
HR20100733T
Other languages
English (en)
Croatian (hr)
Inventor
Henry Wyrobnik Daniel
Harry Wyrobnik Isaac
Original Assignee
Vitacare Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39628203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20100733(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vitacare Gmbh & Co. Kg filed Critical Vitacare Gmbh & Co. Kg
Publication of HRP20100733T1 publication Critical patent/HRP20100733T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52Isomerases (5)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/99Oxidoreductases acting on the CH-OH group of donors (1.1) with other acceptors (1.1.99)
    • C12Y101/99011Fructose 5-dehydrogenase (1.1.99.11)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102Alpha-glucosidase (3.2.1.20)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01026Beta-fructofuranosidase (3.2.1.26), i.e. invertase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y503/00Intramolecular oxidoreductases (5.3)
    • C12Y503/01Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
    • C12Y503/01005Xylose isomerase (5.3.1.5)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR20100733T 2007-02-20 2010-12-31 Glukoza izomeraze za uporabu u liječenju intolerancije fruktoze HRP20100733T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007008664.6A DE102007008664B4 (de) 2007-02-20 2007-02-20 Mittel zur Anwendung bei Fructoseintoleranz
PCT/EP2008/001294 WO2008101672A2 (en) 2007-02-20 2008-02-20 Agent for use in the case of fructose intolerance

Publications (1)

Publication Number Publication Date
HRP20100733T1 true HRP20100733T1 (hr) 2011-02-28

Family

ID=39628203

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20100733T HRP20100733T1 (hr) 2007-02-20 2010-12-31 Glukoza izomeraze za uporabu u liječenju intolerancije fruktoze
HRP20180219TT HRP20180219T1 (hr) 2007-02-20 2018-02-06 Sredstvo za uporabu u slučaju netolerancije na fruktozu

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20180219TT HRP20180219T1 (hr) 2007-02-20 2018-02-06 Sredstvo za uporabu u slučaju netolerancije na fruktozu

Country Status (17)

Country Link
US (10) US8460911B2 (es)
EP (5) EP2124640B1 (es)
AT (1) ATE485832T1 (es)
CA (3) CA2984999A1 (es)
CY (1) CY1120085T1 (es)
DE (2) DE102007008664B4 (es)
DK (3) DK2289352T3 (es)
ES (4) ES2658123T3 (es)
HR (2) HRP20100733T1 (es)
HU (2) HUE041311T2 (es)
IL (1) IL200517A (es)
LT (1) LT2289352T (es)
PL (4) PL2124640T3 (es)
PT (3) PT2289352T (es)
RS (1) RS51896B (es)
SI (2) SI2124640T1 (es)
WO (1) WO2008101672A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007059955A2 (en) * 2005-11-23 2007-05-31 Pro Natura Gesellschaft für gesunde Ernährung mbH Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
DE102007008664B4 (de) 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
WO2010025483A1 (de) 2008-09-04 2010-03-11 Sciotec Diagnostic Technologies Gmbh Behandlung von fruktose-malabsorption
GB201417386D0 (en) 2014-10-01 2014-11-12 Nofima As Sugar-depleted fruit or vegetable juice product, method of producing the same and use thereof to maintain health and treat and to prevent medical ailments
FI127298B (en) 2016-06-23 2018-03-15 Fazer Ab Oy Karl An enzyme with fructan hydrolase activity
EP3793684A4 (en) * 2018-04-18 2022-01-26 Baylor College of Medicine DEVELOPMENT OF AMYLOGLUCOSIDASE AS A MEDICAL FOOD OR FOOD SUPPLEMENT
EP3924486A4 (en) * 2019-02-14 2022-12-07 Gutsybio Inc. LIVING BIOTHERAPEUTICS FOR THE TREATMENT OF CARBOHYDRATE DISORDERS

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083A (en) * 1849-02-06 Cooking-stove
GB1455993A (en) 1973-01-12 1976-11-17 Novo Industri As Glucose isomerase
US4396602A (en) 1981-09-22 1983-08-02 Asahi Kasei Kogyo Kabushiki Kaisha Blood glucose level lowering agents
SE8505783D0 (sv) 1985-12-06 1985-12-06 Rolf Bergkvist Forfarande for framstellning av livsmedelsprodukter och dessas anvendning
US5445957A (en) * 1994-02-10 1995-08-29 Triarco Industries, Inc. Enzyme food supplement composition containing beta-fructofuranosidase, cellulase and hemicellulase
US6306445B1 (en) 1998-05-13 2001-10-23 Novozymes Biotech Inc. Methods for using dehydrogenases in baking
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
JP2000125883A (ja) * 1998-10-21 2000-05-09 Internatl Reagents Corp フルクトキナーゼ及びその遺伝子
AU6326699A (en) 1998-11-05 2000-05-29 Novozymes A/S Methods for using a glucose isomerase in baking
IL138990A0 (en) 1999-02-12 2001-11-25 Biostream Inc Matrices for drug delivery and methods for making and using the same
CA2400969C (en) 2000-03-01 2011-04-19 Societe Des Produits Nestle S.A. Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response to measles vaccine
US6646394B2 (en) 2001-07-09 2003-11-11 Nissan Motor Co., Ltd. Control device for plurality of rotating electrical machines
US20030113310A1 (en) * 2001-12-17 2003-06-19 Van Laere Katrien Maria Jozefa Method for the treatment of obesity, overweight and fluctuations in blood insuline and/or glucose levels
US7067124B2 (en) 2003-03-28 2006-06-27 National Enzyme Company Protease composition and method for treating a digestive disorder
DE102006013624B4 (de) 2005-11-23 2012-03-15 Pro Natura Gesellschaft für gesunde Ernährung mbH Mittel zur Anwendung bei Fructoseintoleranz
JP2009519897A (ja) * 2005-11-16 2009-05-21 プロ・ナトゥーラ・ゲゼルシャフト・ヒューア・ゲズンデ・エルネールング・ミット・ベシュレンクテル・ハフツング フルクトース不耐症の症例での使用のための薬剤
US20090214620A1 (en) 2005-11-23 2009-08-27 Pro Natura Gesellschaft Fuer Gesunde Ernaehrung Mb Agent for use in the case of disorders of blood sugar metabolism, including diabetes
WO2007059956A1 (en) * 2005-11-23 2007-05-31 Pro Natura Gesellschaft für gesunde Ernährung mbH Agent for use in the case of disorders of blood sugar metabolism, including diabetes
WO2007059955A2 (en) * 2005-11-23 2007-05-31 Pro Natura Gesellschaft für gesunde Ernährung mbH Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
DE102007008664B4 (de) 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
US20090060656A1 (en) 2007-08-28 2009-03-05 Allied Tube & Conduit Corporation Paver edging device and method

Also Published As

Publication number Publication date
US20220072111A1 (en) 2022-03-10
CY1120085T1 (el) 2018-12-12
US20180169197A1 (en) 2018-06-21
PT2289352T (pt) 2018-03-09
EP2124640A2 (en) 2009-12-02
RS51896B (en) 2012-02-29
HRP20180219T1 (hr) 2018-04-06
EP2289352A2 (en) 2011-03-02
US20130202694A1 (en) 2013-08-08
PL2289352T3 (pl) 2018-04-30
CA2890721A1 (en) 2008-08-28
WO2008101672A2 (en) 2008-08-28
EP2124640B1 (en) 2010-10-27
DE102007008664A1 (de) 2008-08-21
EP3295954B1 (en) 2018-09-12
EP2289352A3 (en) 2011-05-25
WO2008101672A3 (en) 2009-06-18
PL2124640T3 (pl) 2011-04-29
CA2984999A1 (en) 2008-08-28
DK3295954T3 (da) 2019-01-02
EP3456342A1 (en) 2019-03-20
EP3693005A1 (en) 2020-08-12
ES2658123T3 (es) 2018-03-08
IL200517A0 (en) 2010-04-29
US20130202696A1 (en) 2013-08-08
CA2716421A1 (en) 2008-08-28
DE602008003199D1 (de) 2010-12-09
US8460911B2 (en) 2013-06-11
PT3295954T (pt) 2018-12-17
EP3295954A1 (en) 2018-03-21
ATE485832T1 (de) 2010-11-15
HUE041311T2 (hu) 2019-05-28
US9289474B2 (en) 2016-03-22
CA2890721C (en) 2018-01-09
US9119860B2 (en) 2015-09-01
US11826406B2 (en) 2023-11-28
LT2289352T (lt) 2018-02-26
DK2124640T3 (da) 2011-01-31
IL200517A (en) 2016-06-30
US20130202695A1 (en) 2013-08-08
EP2289352B1 (en) 2017-11-29
US20090311232A1 (en) 2009-12-17
US9155786B2 (en) 2015-10-13
SI2289352T1 (en) 2018-03-30
EP3456342B1 (en) 2020-01-22
US10842854B2 (en) 2020-11-24
US20190282678A1 (en) 2019-09-19
US20170319668A1 (en) 2017-11-09
US20130302411A1 (en) 2013-11-14
HUE10010195T2 (hu) 2018-07-30
PT2124640E (pt) 2011-01-13
PL3295954T3 (pl) 2019-02-28
ES2356357T3 (es) 2011-04-07
PL3456342T3 (pl) 2020-06-15
SI2124640T1 (sl) 2011-03-31
ES2700675T3 (es) 2019-02-18
DE102007008664B4 (de) 2021-07-29
US11147861B2 (en) 2021-10-19
US20160243207A1 (en) 2016-08-25
CA2716421C (en) 2015-07-21
DK2289352T3 (en) 2018-02-12
ES2783989T3 (es) 2020-09-21

Similar Documents

Publication Publication Date Title
HRP20100733T1 (hr) Glukoza izomeraze za uporabu u liječenju intolerancije fruktoze
JP6882789B2 (ja) 食餌性脂肪酸の要求を満たすための方法、組成物、及び装置
Ioannidis et al. Nutritional modulation of the inflammatory bowel response
JP2009519897A5 (es)
RU2015138541A (ru) Композиция, содержащая пищеварительные ферменты и питательные вещества, подходящая для энтерального введения
TW200938214A (en) Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
JP2007000125A (ja) 改質活性炭の製造法及び健康食品としての応用法
JP2007517039A5 (es)
JP5879359B2 (ja) クエン酸及び重炭酸塩を含んでなる医薬組成物、並びにシスチン尿症を治療するためのこれらの使用
CA2623590C (en) A preparation for treatment of non-infectious inflammatory intestinal diseases
JP7069531B2 (ja) ピロロキノリンキノン又はその塩と分岐鎖アミノ酸とを含むカプセル
US20090238796A1 (en) Preparation for treatment of non-infectious inflammatory intestinal diseases
RU2118535C1 (ru) Комплексный бактериальный препарат
JP2008208043A (ja) カルニチン類を含有する固形製剤
US20240269165A1 (en) Fine silicon particle-containing preventive or therapeutic agent for diseases
CN101530406A (zh) 一种复方肠溶制剂及其制备方法
JP2021165269A (ja) 酸化ストレス抑制剤及び抗酸化剤
Tozzi et al. Biological Relevance of Intestinal Gases in Healthy Humans
SIS FLOATING KAPPA CARRAGEENAN BASED HYDROGEL WITH GRAPHENE OXIDE NANOPARTICLES
CN111418838A (zh) 一种激活免疫力抵抗病毒的组合物及其制备方法和应用
CN115137066A (zh) 一种减肥片剂及其制备方法
AU2015245942A1 (en) Methods and compositions for delivering a probiotic
Puneeth Development and Evaluation of Gastroretentive Drug Delivery System for an Anti Diabetic Drug
Shiv Design and evaluation of floating drug delivery system for antimicrobial drug
UA19297U (en) Method for treating herpes of maxillofacial area